gms | German Medical Science

88. Versammlung des Vereins Rhein-Mainischer Augenärzte

Verein Rhein-Mainischer Augenärzte

07.11.2015, Mainz

Approaches to fabricate human artificial cornea with morphogenetically active biopolymers

Meeting Abstract

Search Medline for

  • Werner E. G. Müller - Institut für physiologische Chemie, Universität Mainz
  • Meik Neufurth - Institut für physiologische Chemie, Universität Mainz
  • Xiaohong Wang - Institut für physiologische Chemie, Universität Mainz

Verein Rhein-Mainischer Augenärzte. 88. Versammlung des Vereins Rhein-Mainischer Augenärzte. Mainz, 06.-07.11.2015. Düsseldorf: German Medical Science GMS Publishing House; 2015. Doc15rma26

doi: 10.3205/15rma26, urn:nbn:de:0183-15rma260

Published: November 6, 2015

© 2015 Müller et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

In comparison to the other vertebrate tissues, the morphology of the eye cornea appears to be uncomplex. The cornea is avascular and the tissue is provided with metabolic energy, e.g. glucose and oxygen, through limbal circulation, aqueous liquor as well as film. However, the cornea has to accomplish complex functions, not only to protect the eye and concomitantly to allow light to transmit, but also to support the structural and functional organization of the extracellular fibrillar reticulation into which the keratocytes are embedded, as well as the dense and compact network of nerve endings is several hundred-fold greater than that of the skin. The bioenergetic needs, just to maintain the functional conditions and activities of the ATP hydrolases, involved in the interactions of the cell junctions of the epithelium and endothelium which are bordering the stroma, and the membrane potential of the nerve terminals are huge. The regeneration capacity of the cornea is low, also due to the slow cycling cell rate of the limbal stem cells that give rise to the corneal epithelial cells. In turn, impairment of cornea often requires the transplantation of donated corneal tissue/grafts of different coverage, ranging from penetrating keratoplasty to lamellar keratoplasty. Worldwide approximately 300 million individuals suffer from visual impairment, of which 40 million patients are blind.

Even though grafting of donor cornea is a sufficiently established technique and frequently applied, like at the University Medical Center/Cornea Bank of Rhineland-Palatine, Mainz Germany, donor corneas are only insufficiently available. Therefore, alternatives to donor corneas have to be developed. Principally, two routes had been followed to reduce this problem, FIRST the design and development of prosthetic corneas, the keratoprostheses, with the Boston- as well as the osteo-odonto-type of prostheses as examples, and SECOND decellularized animal corneas, e.g. porcine corneas. Allografting as well as xenografting approaches are, to some extent, promising in cornea transplantation, due to the restricted immune defense capacity of the cornea.

Fibrillar collagen, the major organic component in the cornea, controls not only the transmission of visible light but also the attachment and patterning of the cells in this tissue. One of the important characteristics of collagen is its unique posttranslational modifications, especially the covalent intermolecular cross-linking. The enzyme-mediated cross-linking, mediated by lysyl oxidase, is crucially dependent on the extent of hydroxylation of specific lysine (Lys) residues in the collagen molecule as well as the extent of oxidative deamination of the Lys and hydroxylysine (Hyl). In addition, the glycosylation pattern at helical Hyl residues, involved in cross-linking, modulate the maturation of collagen cross-links. Artificial cross-linking of proteins or also collagen with EDC [1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide] results in the formation of an amide or ester bond, with some minor unwanted side reactions, e.g. a rearrangement to stable N-acylurea.

In our approach we use silica-based as well as polyphosphate-based biopolymers (Figure 1 [Fig. 1]) to fabricate transparent cornea with the required mechanical stabilities. First examples will be presented.


References

1.
Müller WE, Tolba E, Schröder HC, Wang X. Polyphosphate: A Morphogenetically Active Implant Material Serving as Metabolic Fuel for Bone Regeneration. Macromol Biosci. 2015 Sep;15(9):1182-97. DOI: 10.1002/mabi.201500100 External link
2.
Müller WE, Neufurth M, Huang J, Wang K, Feng Q, Schröder HC, Diehl-Seifert B, Muñoz-Espí R, Wang X. Nonenzymatic Transformation of Amorphous CaCO3 into Calcium Phosphate Mineral after Exposure to Sodium Phosphate in Vitro: Implications for in Vivo Hydroxyapatite Bone Formation. Chembiochem. 2015 Jun;16(9):1323-32. DOI: 10.1002/cbic.201500057 External link
3.
Müller WE, Tolba E, Feng Q, Schröder HC, Markl JS, Kokkinopoulou M, Wang X. Amorphous Ca²⁺ polyphosphate nanoparticles regulate the ATP level in bone-like SaOS-2 cells. J Cell Sci. 2015 Jun;128(11):2202-7. DOI: 10.1242/jcs.170605 External link
4.
Müller WEG, Tolba E, Dorweiler B, Schröder HC, Diehl-Seifert B, Wang XH. Electrospun bioactive mats enriched with Ca-polyphosphate/retinol nanospheres as potential wound dressing. Biochem Biophys Rep. 2015;3:150-60. DOI: 10.1016/j.bbrep.2015.08.007 External link
5.
Wang X, Schröder HC, Müller WE. Polyphosphate as a metabolic fuel in Metazoa: A foundational breakthrough invention for biomedical applications. Biotechnol J. 2015 Sep. DOI: 10.1002/biot.201500168 External link
6.
Müller WE, Schröder HC, Tolba E, Diehl-Seifert B, Wang X. Mineralization of bone-related SaOS-2 cells under physiological hypoxic conditions. FEBS J. 2015 Oct. DOI: 10.1111/febs.13552 External link